N-of-One will interpret data from HemeSeq profiles for acute myeloid leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and other cancers.
The newly minted company offers panel, whole-genome and whole exome sequencing, as well as bioinformatics analysis and reporting services to oncologists.
GeneWiz will implement multiple Dragen processors to reduce turnaround times for its genomic data analysis services business.
The firm is launching a service that will enable researchers to incorporate genetics into studies and incentivize participation with a 23andMe account.
The company intends to provide no-cost subscriptions to the Cloudera platform for storage, processing, and analyzing big data to researchers at some 50 institutions.
Patronus will use BaseHealth's platform to provide health assessments based on patients' genomics, medical histories, and environmental risk factors.
Era7 is leading an effort to develop a platform for analyzing patient microbiomes that could be integrated with hospitals' EHRs.
PierianDx raised $9 million in Series A funding, which it is using to hire staff and further develop its software including support for clinical whole-genome sequencing.
Under the terms of the agreement, Insilico Medicine will integrate unspecified data assets and the staff of Belgian bioinformatics company InSilico Screen.
N-of-One will provide clinical and scientific evidence that supports personalized treatment recommendations made on the basis of WuXi Nextcode's tumor-normal sequence interpretation.
In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.
Technology Review points out that a new US presidential science advisor hasn't been selected.
Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.
President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.